{"id":11016,"date":"2026-10-12T16:01:38","date_gmt":"2026-10-12T14:01:38","guid":{"rendered":"https:\/\/mumak.me\/?p=11016"},"modified":"2026-10-13T04:11:21","modified_gmt":"2026-10-13T02:11:21","slug":"weekly-market-overview-october-5-october-11-2026","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/portfolio-updates\/weekly-update\/weekly-market-overview-october-5-october-11-2026\/","title":{"rendered":"Weekly Market Overview \u2013 October 5\u2013October 11, 2026"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The past week was characterized by further portfolio adjustments within the UMBRELLA Strategy. The focus on artificial intelligence<\/strong>, advanced technologies<\/strong>, and AI infrastructure<\/strong> was further strengthened.<\/p>

Positions in Palantir Technologies<\/a><\/strong> and SpaceX<\/a><\/strong> were increased once again. With Dell Technologies<\/a><\/strong>, a new company was also added to the strategy. At the same time, the weighting of selected healthcare stocks was reduced.<\/p>

Bayer<\/a><\/strong> was completely sold out of the UMBRELLA Strategy following persistent price weakness. Positions in Revolution Medicines<\/a><\/strong> and Johnson & Johnson<\/a><\/strong> were also partially reduced.<\/p>

Following these adjustments, the strategy comprises nine positions with an equity ratio of approximately 97.4% and a cash component of 2.6%.<\/p>

Overview of portfolio changes<\/span><\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t

Increased<\/h2>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Palantir Technologies<\/a><\/p>

SpaceX<\/a><\/p>

Dell Technologies<\/a><\/strong> NEU<\/span><\/code><\/strong><\/span><\/p> \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t

Reduced<\/h2>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Revolution Medicines<\/a><\/p>

Johnson & Johnson<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/circle><\/path><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t

Sold<\/h2>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Bayer<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Technology and AI weighting continues to rise<\/h2>

The rotation toward artificial intelligence<\/strong> and advanced technologies<\/strong> continued throughout the week.<\/p>

Palantir Technologies<\/a><\/strong> became the largest position in the UMBRELLA Strategy with a weighting of 18.8%, closely followed by SpaceX<\/a><\/strong> at 18.2%.<\/p>

Both positions were further increased. This enhanced the focus on AI, data-driven software, and advanced technologies.<\/p>

Together with Micron Technology<\/a><\/strong>, Intel<\/a><\/strong>, Alphabet, and the newly added Dell Technologies<\/a><\/strong>, these companies now represent the vast majority of the portfolio. This underscores the strategy’s increasing concentration on technology-related themes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\"Allocation\t<\/a>\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Palantir becomes largest position<\/h2>

Palantir Technologies<\/a><\/strong> continued to gain weight during the week and became the largest individual position in the UMBRELLA Strategy.<\/p>

Following further purchases, the weighting reached 18.8%. Palantir<\/a><\/strong> thus remains a central component of the portfolio’s AI orientation.<\/p>

SpaceX position further increased<\/h2>

The position in SpaceX<\/a><\/strong> was also further expanded during the week.<\/p>

Through additional purchases, the weighting rose to 18.2%. SpaceX<\/a><\/strong> thus continues to be among the largest positions in the UMBRELLA Strategy and remains an important part of the focus on advanced technologies.<\/p>

Together, Palantir and SpaceX<\/a><\/strong> account for approximately 37% of the portfolio. This illustrates their growing importance within the current strategy.<\/p>

Dell Technologies new to the UMBRELLA Strategy<\/h2>

Dell Technologies<\/a><\/strong> has been newly added to the UMBRELLA Strategy.<\/p>

The company provides access to the fields of servers, data center infrastructure, and enterprise IT, which are increasingly shaped by investments in artificial intelligence.<\/p>

Following its inclusion, the weighting of Dell Technologies<\/a><\/strong> is 3.2%.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Dell Technologies –<\/a> Stock Profile Summary<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Semiconductors remain an important component<\/h2>

Micron Technology<\/a><\/strong> and Intel remain significant positions within the UMBRELLA Strategy.<\/p>

Micron Technology<\/a><\/strong> accounts for 11.5% of the portfolio, while Intel is weighted at 10.2%.<\/p>

Together, both companies reach a share of approximately 21.7%, thereby continuing to ensure a significant orientation toward the semiconductor sector.<\/p>

Healthcare sector further reduced<\/h2>

The healthcare sector remains an important part of the UMBRELLA Strategy, but its weighting was further reduced during the week.<\/p>

Revolution Medicines<\/a><\/strong> was partially reduced following positive price development. With a weighting of 15.3%, the company nevertheless remains the third-largest position and the largest healthcare asset in the portfolio.<\/p>

Also Johnson & Johnson<\/a><\/strong> was reduced. This freed up capital for the continued rotation into technology stocks. The position currently makes up 6.4% of the portfolio.<\/p>

Eli Lilly<\/a><\/strong> remains part of the strategy with a weighting of 9.5%.<\/p>

These companies continue to ensure targeted engagement in the healthcare sector alongside the growing technology weighting.<\/p>

Bayer leaves the UMBRELLA Strategy<\/h2>

Bayer<\/a><\/strong> was sold completely from the UMBRELLA Strategy during the week.<\/p>

The position was closed following persistent price weakness.<\/p>

The exit intensifies the portfolio’s concentration on artificial intelligence, semiconductors, advanced technologies, and selected healthcare companies.<\/p>

Current positioning of the UMBRELLA Strategy<\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\n
\n
\n
\n

Current Positioning<\/h3>\n

UMBRELLA Strategy \u00b7 October 12, 2026<\/p>\n <\/div>\n 9 Positions<\/span>\n <\/div>\n\n

\n
\n Equity allocation<\/span>\n 97.4%<\/strong>\n
<\/div><\/div>\n <\/div>\n
\n Cash<\/span>\n 2.6%<\/strong>\n
<\/div><\/div>\n <\/div> \n <\/div>\n\n
\n Position \/ Weighting<\/span>\n Performance since inclusion<\/span>\n <\/div>\n\n
\n
\n
\n Palantir Technologies<\/strong>\n
<\/div><\/div>18.7%<\/span><\/div>\n <\/div>\n +16.4%<\/span>\n <\/div>\n\n
\n
\n SpaceX<\/strong>\n
<\/div><\/div>18.1%<\/span><\/div>\n <\/div>\n +14.0%<\/span>\n <\/div>\n\n
\n
\n Revolution Medicines<\/strong>\n
<\/div><\/div>15.7%<\/span><\/div>\n <\/div>\n +20.1%<\/span>\n <\/div>\n\n
\n
\n Micron Technology<\/strong>\n
<\/div><\/div>11.3%<\/span><\/div>\n <\/div>\n \u22125.3%<\/span>\n <\/div>\n\n
\n
\n Intel<\/strong>\n
<\/div><\/div>10.0%<\/span><\/div>\n <\/div>\n \u221213.1%<\/span>\n <\/div>\n\n
\n
\n Eli Lilly<\/strong>\n
<\/div><\/div>9.5%<\/span><\/div>\n <\/div>\n +10.3%<\/span>\n <\/div>\n\n
\n
\n Johnson & Johnson<\/strong>\n
<\/div><\/div>6.5%<\/span><\/div>\n <\/div>\n +10.2%<\/span>\n <\/div>\n\n
\n
\n Alphabet A (Google)<\/strong>\n
<\/div><\/div>4.4%<\/span><\/div>\n <\/div>\n +3.3%<\/span>\n <\/div>\n\n
\n
\n Dell Technologies<\/strong>\n
<\/div><\/div>3.1%<\/span><\/div>\n <\/div>\n \u22120.3%<\/span>\n <\/div>\n <\/div>\n\n

Source: wikifolio.com, UMBRELLA \u00b7 As of: October 12, 2026<\/p>\n<\/div>\n\n\n.umbrella-portfolio {\n --up-blue: #31566A;\n --up-gold: #C7A257;\n --up-bg: #F7F9FA;\n --up-line: #E3E9ED;\n font-family: inherit;\n color: #303C42;\n background: #fff;\n border: 1px solid var(--up-line);\n border-radius: 12px;\n padding: 20px;\n width: 100%;\n box-sizing: border-box;\n}\n.umbrella-portfolio * { box-sizing: border-box; }\n.umbrella-portfolio .up-head {\n display: flex;\n justify-content: space-between;\n align-items: flex-start;\n gap: 10px;\n margin-bottom: 18px;\n}\n.umbrella-portfolio .up-head h3 {\n font-size: 18px;\n line-height: 1.3;\n color: var(--up-blue);\n margin: 0 0 5px;\n font-weight: 700;\n}\n.umbrella-portfolio .up-head p {\n font-size: 11px;\n color: #74838A;\n margin: 0;\n}\n.umbrella-portfolio .up-count {\n background: #EAF0F3;\n color: var(--up-blue);\n border-radius: 20px;\n padding: 5px 9px;\n font-size: 10px;\n white-space: nowrap;\n font-weight: 600;\n}\n.umbrella-portfolio .up-summary {\n display: grid;\n grid-template-columns: repeat(2, minmax(0,1fr));\n gap: 10px;\n margin-bottom: 22px;\n}\n.umbrella-portfolio .up-summary-card {\n background: var(--up-bg);\n border-radius: 8px;\n padding: 12px;\n min-width: 0;\n}\n.umbrella-portfolio .up-summary-card > span {\n display: block;\n font-size: 11px;\n color: #71818A;\n margin-bottom: 5px;\n}\n.umbrella-portfolio .up-summary-card > strong {\n display: block;\n font-size: 22px;\n color: var(--up-blue);\n line-height: 1.3;\n margin-bottom: 10px;\n font-weight: 700;\n}\n.umbrella-portfolio .up-track {\n height: 6px;\n background: #E4E9ED;\n border-radius: 20px;\n overflow: hidden;\n flex: 1;\n min-width: 0;\n}\n.umbrella-portfolio .up-fill {\n height: 100%;\n background: var(--up-blue);\n border-radius: 20px;\n}\n.umbrella-portfolio .up-gold {\n background: var(--up-gold);\n}\n.umbrella-portfolio .up-labels {\n display: flex;\n justify-content: space-between;\n gap: 10px;\n color: var(--up-blue);\n font-size: 10px;\n font-weight: 700;\n margin-bottom: 10px;\n}\n.umbrella-portfolio .up-labels span:last-child {\n text-align: right;\n max-width: 125px;\n}\n.umbrella-portfolio .up-item {\n display: flex;\n align-items: center;\n justify-content: space-between;\n gap: 12px;\n border-bottom: 1px solid #EDF0F2;\n padding: 11px 0;\n transition: background .2s ease, padding .2s ease;\n}\n.umbrella-portfolio .up-item:hover {\n background: #F4F8FA;\n border-radius: 5px;\n padding-left: 6px;\n padding-right: 6px;\n}\n.umbrella-portfolio .up-position {\n flex: 1;\n min-width: 0;\n}\n.umbrella-portfolio .up-position > strong {\n display: block;\n font-size: 12px;\n line-height: 1.4;\n font-weight: 600;\n margin-bottom: 7px;\n}\n.umbrella-portfolio .up-weight {\n display: flex;\n align-items: center;\n gap: 9px;\n}\n.umbrella-portfolio .up-weight > span {\n font-size: 11px;\n font-weight: 600;\n white-space: nowrap;\n width: 45px;\n text-align: right;\n}\n.umbrella-portfolio .up-positive,\n.umbrella-portfolio .up-negative {\n font-size: 12px;\n font-weight: 700;\n text-align: right;\n white-space: nowrap;\n min-width: 62px;\n}\n.umbrella-portfolio .up-positive { color: #198754; }\n.umbrella-portfolio .up-negative { color: #C94444; }\n.umbrella-portfolio .up-source {\n font-size: 10px;\n line-height: 1.5;\n color: #829098;\n font-style: italic;\n margin: 15px 0 0;\n}\n@media (max-width: 767px) {\n .umbrella-portfolio { padding: 14px; }\n .umbrella-portfolio .up-head h3 { font-size: 16px; }\n .umbrella-portfolio .up-summary-card { padding: 10px; }\n .umbrella-portfolio .up-summary-card > strong { font-size: 19px; }\n .umbrella-portfolio .up-item { gap: 8px; }\n .umbrella-portfolio .up-position > strong { font-size: 11px; }\n .umbrella-portfolio .up-positive,\n .umbrella-portfolio .up-negative { font-size: 11px; min-width: 55px; }\n}\n@media (prefers-reduced-motion: reduce) {\n .umbrella-portfolio .up-item { transition: none; }\n}\n\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Outlook: AI and advanced technologies remain in focus<\/h2>

The UMBRELLA Strategy enters the new week with a stronger concentration on artificial intelligence<\/strong>, semiconductors<\/strong>, and advanced technologies<\/strong>. At the same time, a targeted commitment to the healthcare sector remains in place.<\/p>

With Palantir<\/a><\/strong> and SpaceX<\/a><\/strong> as the two largest positions, developments in AI software, infrastructure, and advanced technologies continue to gain importance for the portfolio.<\/p>

The addition of Dell Technologies<\/a><\/strong> expands the focus on AI infrastructure, while Micron Technology<\/strong><\/a> and Intel continue to ensure a significant semiconductor weighting.<\/p>

At the same time, Revolution Medicines<\/a><\/strong>, Eli Lilly<\/a><\/strong>, and Johnson & Johnson<\/a><\/strong> remain important representatives of the healthcare sector.<\/p>

Company-specific developments, fundamental dynamics, and technical market signals remain critical factors for future portfolio adjustments.<\/p>

<\/h3>

UMBRELLA Strategy: Weekly Video Update<\/h2>

In addition to our weekly review, the current video update<\/strong> offers further insights into developments surrounding the UMBRELLA Strategy<\/strong> and the current market environment.<\/p>

The video complements the portfolio analysis and provides additional perspectives on the strategy’s current positioning.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Palantir becomes the largest UMBRELLA position. SpaceX gains, Dell is added, and Bayer exits. The focus on AI and technology grows.<\/p>\n","protected":false},"author":2,"featured_media":2174,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[40],"tags":[551,281,340,129,97],"aktie":[],"class_list":["post-11016","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-weekly-update","tag-spacex","tag-kuenstliche-intelligenz","tag-palantir","tag-technologie","tag-umbrella-strategie"],"acf":[],"_links":{"self":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/11016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/comments?post=11016"}],"version-history":[{"count":17,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/11016\/revisions"}],"predecessor-version":[{"id":11110,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/11016\/revisions\/11110"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media\/2174"}],"wp:attachment":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media?parent=11016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/categories?post=11016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/tags?post=11016"},{"taxonomy":"aktie","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/aktie?post=11016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}